InvestSMART

Capitol Health Limited (ASX: CAJ) - Announcements

DELISTED - Current share price for CAJ : $0.385

ASX company news and announcements for Capitol Health Limited (CAJ) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Capitol Health Limited (CAJ) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Capitol Health Limited (CAJ), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Capitol Health Limited (CAJ)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
- Change of Director's Interest Notice 22 Aug 2024 7:40AM $0.295 $0.385 risen by 30.51%
- Notification of cessation of securities - CAJ 22 Aug 2024 7:36AM $0.295 $0.385 risen by 30.51%
- Corporate Governance Statement 22 Aug 2024 7:36AM $0.295 $0.385 risen by 30.51%
- Appendix 4G 22 Aug 2024 7:32AM $0.295 $0.385 risen by 30.51%
- Final share buy-back notice 22 Aug 2024 7:30AM $0.295 $0.385 risen by 30.51%
- FY24 Results Presentation 22 Aug 2024 7:30AM $0.295 $0.385 risen by 30.51%
- FY24 Results Release Announcement 22 Aug 2024 7:30AM $0.295 $0.385 risen by 30.51%
- Appendix 4E and Annual Report 22 Aug 2024 7:30AM $0.295 $0.385 risen by 30.51%
- Ceasing to be a substantial holder 12 Aug 2024 4:49PM $0.300 $0.385 risen by 28.33%
- Change in substantial shareholding from AEF 6 Aug 2024 5:37PM $0.295 $0.385 risen by 30.51%
- FY24 Financial Results Release Date 31 Jul 2024 8:16AM $0.300 $0.385 risen by 28.33%
- Variation of MD/CEO's Employment Agreement 18 Jul 2024 5:39PM $0.295 $0.385 risen by 30.51%
- IDX: IDX/CAJ Merger Investor Presentation 18 Jul 2024 4:22PM $0.295 $0.385 risen by 30.51%
- CAJ enters into Merger Implementation Deed with IDX 18 Jul 2024 4:21PM $0.295 $0.385 risen by 30.51%
- IDX: IDX & CAJ Sign Merger Implementation Deed 18 Jul 2024 4:21PM $0.295 $0.385 risen by 30.51%
- Notification regarding unquoted securities - CAJ 9 Jul 2024 8:51AM $0.303 $0.385 risen by 27.27%
- Change in substantial shareholding from AEF 2 Jul 2024 3:27PM $0.305 $0.385 risen by 26.23%
- IDX: Integral Diagnostics & Capitol Health Proposed Merger 17 Jun 2024 9:27AM $0.245 $0.385 risen by 57.14%
- CAJ enters Process Deed following IDX's Indicative Proposal 17 Jun 2024 9:16AM $0.245 $0.385 risen by 57.14%
- Notification of cessation of securities - CAJ 3 May 2024 4:35PM $0.240 $0.385 risen by 60.42%
- Change in substantial holding from WAM/WMI/WAX 24 Apr 2024 5:28PM $0.240 $0.385 risen by 60.42%
- Notification of cessation of securities - CAJ 8 Apr 2024 8:59AM $0.245 $0.385 risen by 57.14%
- Application for quotation of securities - CAJ 5 Apr 2024 4:02PM $0.245 $0.385 risen by 57.14%
- Section 708A Cleansing Statement 5 Apr 2024 4:00PM $0.245 $0.385 risen by 57.14%
- Update - Dividend/Distribution - CAJ 14 Mar 2024 5:04PM $0.245 $0.385 risen by 57.14%

51 - 75 of 756 results

Page 3 of 31

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.